Inducible deletion of skeletal muscle AMPKα 1 reveals that AMPK is required for nucleotide balance but dispensable for muscle glucose uptake and fat oxidation during exercise by Hingst, Janne Rasmuss et al.
u n i ve r s i t y  o f  co pe n h ag e n  
Inducible deletion of skeletal muscle AMPK 1 reveals that AMPK is required for
nucleotide balance but 2 dispensable for muscle glucose uptake and fat oxidation
during exercise
Hingst, Janne Rasmuss; Kjøbsted, Rasmus; Birk, Jesper Bratz; Jørgensen, Nicolas
Oldenburg; Larsen, Magnus R; Kido, Kohei; Larsen, Jeppe Kjærgaard; Kjeldsen, Sasha
Alexandra Sampson; Fentz, Joachim; Frøsig, Christian; Holm, Stephanie; Fritzen, Andreas
Mæchel; Dohlmann, Tine Lovsø; Larsen, Steen; Foretz, Marc; Viollet, Benoit; Schjerling,
Peter; Overby, Peter; Halling, Jens Frey; Pilegaard, Henriette; Hellsten, Ylva; Wojtaszewski,
Jørgen
Published in:
Molecular Metabolism
DOI:
10.1016/j.molmet.2020.101028
Publication date:
2020
Document version
Publisher's PDF, also known as Version of record
Document license:
CC BY
Citation for published version (APA):
Hingst, J. R., Kjøbsted, R., Birk, J. B., Jørgensen, N. O., Larsen, M. R., Kido, K., ... Wojtaszewski, J. (2020).
Inducible deletion of skeletal muscle AMPK 1 reveals that AMPK is required for nucleotide balance but 2
dispensable for muscle glucose uptake and fat oxidation during exercise. Molecular Metabolism, 40, [101028].
https://doi.org/10.1016/j.molmet.2020.101028
Download date: 09. okt.. 2020
Original ArticleInducible deletion of skeletal muscle AMPKa
reveals that AMPK is required for nucleotide
balance but dispensable for muscle glucose
uptake and fat oxidation during exerciseJanne R. Hingst 1,8, Rasmus Kjøbsted 1,8, Jesper B. Birk 1, Nicolas O. Jørgensen 1, Magnus R. Larsen 1,
Kohei Kido 1, Jeppe Kjærgaard Larsen 1, Sasha A.S. Kjeldsen 1, Joachim Fentz 1, Christian Frøsig 1,
Stephanie Holm 1, Andreas M. Fritzen 1, Tine L. Dohlmann 2, Steen Larsen 2,3, Marc Foretz 4, Benoit Viollet 4,
Peter Schjerling 5, Peter Overby 6, Jens F. Halling 6, Henriette Pilegaard 6, Ylva Hellsten 7,
Jørgen F.P. Wojtaszewski 1,*ABSTRACT
Objective: Evidence for AMP-activated protein kinase (AMPK)-mediated regulation of skeletal muscle metabolism during exercise is mainly
based on transgenic mouse models with chronic (lifelong) disruption of AMPK function. Findings based on such models are potentially biased by
secondary effects related to a chronic lack of AMPK function. To study the direct effect(s) of AMPK on muscle metabolism during exercise, we
generated a new mouse model with inducible muscle-specific deletion of AMPKa catalytic subunits in adult mice.
Methods: Tamoxifen-inducible and muscle-specific AMPKa1/a2 double KO mice (AMPKa imdKO) were generated by using the Cre/loxP system,
with the Cre under the control of the human skeletal muscle actin (HSA) promoter.
Results: During treadmill running at the same relative exercise intensity, AMPKa imdKO mice showed greater depletion of muscle ATP, which
was associated with accumulation of the deamination product IMP. Muscle-specific deletion of AMPKa in adult mice promptly reduced maximal
running speed and muscle glycogen content and was associated with reduced expression of UGP2, a key component of the glycogen synthesis
pathway. Muscle mitochondrial respiration, whole-body substrate utilization, and muscle glucose uptake and fatty acid (FA) oxidation during
muscle contractile activity remained unaffected by muscle-specific deletion of AMPKa subunits in adult mice.
Conclusions: Inducible deletion of AMPKa subunits in adult mice reveals that AMPK is required for maintaining muscle ATP levels and nucleotide
balance during exercise but is dispensable for regulating muscle glucose uptake, FA oxidation, and substrate utilization during exercise.
 2020 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Physical activity is associated with a marked increase in muscle
metabolism and energy turnover [1]. Therefore, maintaining intracel-
lular levels of adenosine triphosphate (ATP) during exercise represents
a metabolic challenge for the muscle cell. The increased ATP turnover
during exercise leads to accumulation of intramyocellular adenosine
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ATP þ AMP) [2]. The increased intramyocellular AMP/ATP ratio leads
to activation of the 50-AMP-activated protein kinase (AMPK) [3], which
promotes catabolic processes and inhibits anabolic processes to
normalize the cellular energy status [4]. On this basis, skeletal muscle
AMPK is proposed to function as a cellular energy sensor activated
during exercise and thus to act as a central mediator of cellular
signaling to maintain energy homeostasis.of Science, University of Copenhagen, DK-2100, Copenhagen, Denmark 2Section of
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Original ArticleBecause of AMPK’s pivotal role in the regulation of muscle meta-
bolism, it provides a putative therapeutic target for metabolic dis-
orders, such as type 2 diabetes (T2D) [5]. Acute pharmacological
activation of AMPK in rodent muscle by different pharmacological
agents (e.g., AICAR, PF739, MK-8722) promotes glucose disposal
and fatty acid (FA) oxidation [6e8]. However, AMPK-deficient mouse
models have provided conflicting results as to whether AMPK acti-
vation is required for muscle metabolism to cope with cellular energy
stress during exercise. Although reduced muscle glucose uptake has
been reported in AMPK-deficient mice during in vivo treadmill ex-
ercise and during contraction of isolated mouse muscles in some
studies [9e15], other studies have demonstrated intact muscle
glucose uptake during contractile activity [16e22]. Knockout (KO) of
the two regulatory AMPKb subunits (AMPKb1b2MKO) is associ-
ated with impaired muscle glucose uptake and increased FA
oxidation during treadmill exercise [9], and KO of both catalytic
AMPKa subunits (AMPKa1/a2) in muscle (AMPKa mdKO mice) or
KO of the AMPK upstream kinase LKB1 (liver kinase B1) (LKB1 KO
mice) leads to increased reliance on glucose as a substrate during
treadmill exercise [16,17]. However, a direct interpretation of these
findings is confounded by disrupted mitochondrial capacity [9,17]
and changes in expression of key proteins/enzymes involved in lipid
metabolism (e.g. CD36 and FABPpm) in these models [16,17]. In
most studies, maximal treadmill running speed is reduced in AMPK-
deficient mice compared to littermate controls (see [23] for detailed
review). During high metabolic stress, the muscle cell prevents
accumulation of AMP by converting it to inosine monophosphate
(IMP) in an AMP deaminase (AMPD) dependent reaction that serves
to maintain a homeostatic ATP/ADP ratio [24]. Accelerated ATP
degradation and reduced glucose uptake have been observed in
skeletal muscle of mice overexpressing a kinase-dead AMPKa2
construct (AMPKa2 KD mice) [10]. Whether these findings can be
ascribed directly to the lack of functional AMPK or should be
considered a consequence of the marked impairment in mitochon-
drial function reported for this model remains unclear [10].
In summary, the findings in the literature on AMPK-deficient mouse
models indicate that the observed phenotypes may be ascribed to
secondary effects due to the lifelong lack of AMPK rather than the
acute regulation of AMPK activity. To study the direct effect(s) of AMPK
activation during exercise, we developed a new mouse model where
AMPK catalytic activity can be deleted in a muscle-specific manner at a
specific time point in adult mice. With this new model, we attempted to
clarify the direct role of AMPK in exercise-stimulated regulation of
muscle metabolism.
2. MATERIALS AND METHODS
2.1. Generation of the tamoxifen-inducible muscle-specific AMPKa
double knockout mouse model (AMPKa imdKO)
Inducible muscle-specific double AMPKa1/a2 KO mice (AMPKa
imdKO) were generated by breeding double-floxed AMPKa1a2 mice
(AMPKa1fl/fl, AMPKa2fl/fl) [15] with mice expressing a tamoxifen-
inducible Cre-recombinase driven by the human skeletal actin pro-
moter (HSA-MCMþ/-) [25]. Deletion of AMPKa1/a2 in skeletal muscle
was achieved by intraperitoneal injection of tamoxifen (Cat. No. T5648,
SigmaeAldrich) dissolved in 99% ethanol and resuspended in sun-
flower seed oil (Cat. No. S5007, SigmaeAldrich). The tamoxifen
treatment protocol comprised 3 single injections (40 mg/kg body
weight) each separated by 48 h. Female double-floxed AMPKa1a2
control mice (AMPKa1fl/fl, AMPKa2fl/fl, HSA-MCM/) and AMPKa2
 2020 The Authors. Published by Elsevier GimdKO mice (AMPKa1fl/fl, AMPKa2fl/fl, HSA-MCMþ/-) on a mixed
background (C57/Bl6w87.5% and SV129w12.5%) were used in all
experiments.
Initially, a time course study was performed to determine the earliest
time point for optimal deletion of skeletal muscle AMPKa protein. For
this time course experiment, mice were investigated 1, 3, and 8 weeks
after the final tamoxifen injection and compared to vehicle-injected
control mice (sunflower seed oil injections). Three weeks after the
last tamoxifen injection was the earliest time point with optimal
deletion of AMPKa protein; therefore, all subsequent experiments were
performed w3 weeks after the final tamoxifen injection. Both the
AMPKa imdKO mice and AMPKa double-floxed control littermates
aged 12  5 weeks (mean  SD) were treated with tamoxifen. The
tamoxifen administration protocol applied in this study resulted in
substantial testicular swelling in male mice (unpublished observa-
tions); thus, for ethical and experimental reasons, we performed all
subsequent experiments in female mice only. All mice had free access
to water and rodent chow and were maintained on a 12:12 h lighte
dark cycle. All experiments were approved by the Danish Animal Ex-
periments Inspectorate (License #2013-15-2934-00911, #2014-15-
2934-01037 and #2019-15-0201-01659) and complied with the
European Union guidelines for the protection of vertebra animals used
for scientific purposes.
2.2. Body composition and morphological analyses
Body composition was measured before andw3 weeks after the final
tamoxifen injection by the use of magnetic resonance imaging
(EchoMRI 4-in-1; EchoMRI, Houston, TX). Skeletal muscle, heart, white
adipose tissue, liver, and kidney were carefully dissected from anes-
thetized control and AMPKa imdKO mice and visually inspected for
signs of disparity. Tissue mass was determined with 0.1 mg accuracy
(ED124S, Sartorius, Goettingen, Germany).
2.3. Basal calorimetry
Before the measurements, mice were acclimatized for 3 days to
individually housed airtight calorimetric cages connected to an indirect
calorimetric system (Phenomaster/LabMaster system; TSE Systems,
Bad Homburg, Germany). O2 consumption (VO2), CO2 production
(VCO2), food intake, and physical activity level (laser beam breaks)
were recorded for a 48-hour period while the mice were receiving a
chow diet (Altromin no. 1324; Brogaarden, Horsholm, Denmark) and
then a high-fat diet (HFD; 60% kcal derived from fat; no. D12492;
Brogaarden, Horsholm, Denmark). After a 24-hour washout period on a
regular chow diet, the effect of 24 h of fasting was investigated. For all
calorimetric measurements, mice were maintained on a 12 h:12 h
lightedark cycle and housed at 20e21 C.
2.4. Treadmill acclimatization and maximal exercise capacity test
On 3 separate days (Pre, 1 week, and 3 weeks after final tamoxifen
injection), mice were adapted to a treadmill running system (TSE
Systems). The adaptation protocol comprised 5 min rest followed by
5 min running at 7.2 m/min and 5 min running at 9.6 m/min [16]. After
1 day of rest, a graded exercise capacity test was performed. The test
was initiated by 5 min rest and the following task was treadmill running
at 4.8 m/min where the treadmill speed increased 2.4 m/min every
2 min at a 5 incline. Mice were forced to run by the use of pressurized
air and an electric shocker grid at the back of the treadmill. Exhaustion
was reached when the mice stayed on the shocking grid despite
repeated agitation with pressurized air. The last passed speed level
was defined as maximal running speed.MOLECULAR METABOLISM 40 (2020) 101028
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2.5. Substrate utilization during treadmill exercise
Substrate utilization during treadmill exercise was investigated at least
48 h after the maximal exercise capacity test by measuring O2 con-
sumption (VO2) and CO2 production (VCO2) in an airtight treadmill
running system (CaloSys apparatus; TSE Systems, Germany). Mice
were placed on the calorimetric treadmill and allowed to rest for
10 min. Next, the mice were forced to perform a 5-min warm-up at
40% of maximal treadmill running speed and 30 min continuous
running at 60% of individual maximal running speed at a 5 incline.
Measurements continued 15 min into exercise recovery.
2.6. Glucose uptake measurements during treadmill exercise
Mice either rested or exercised for 30 min at 70% of individual maximal
running speed at a 15 incline. Intraperitoneal injection of saline con-
taining [3H]-2-deoxyglucose ([3H]-2-DG) (8 ml/kg, 60 mCi/ml, Perkin
Elmer, USA) was administered 20 min before the onset of exercise/rest.
Blood samples in combination with blood glucose measurements
(Contour XT, Bayer, Germany) were obtained from the tail vein imme-
diately before and after exercise/rest to determine specific radioactivity
in the blood. Mice were euthanized by cervical dislocation immediately
after the last blood sample was drawn, and tissues were quickly har-
vested and frozen in liquid nitrogen. Muscle 2-DG uptake was deter-
mined as [3H]-2-deoxy-D-glucose-6-phosphate ([3H]-2-DG-6-P)
content by Somogyi and perchloric acid precipitations of muscle ho-
mogenate, as described in the literature [16,26].
2.7. Glucose and insulin tolerance tests
For all tests, mice were individually housed. For the glucose tolerance
test (GTT), mice were fasted for 5 h in the morning before they were
given an intraperitoneal injection of glucose (2 g/kg body weight)
dissolved in a 0.9% saline solution. For the insulin tolerance test (ITT),
overnight fed mice were fasted for 2 h in the morning before they were
given an intraperitoneal injection of insulin (1 U/kg body weight,
Actrapid, Novo Nordisk, Bagsværd, Denmark). Blood was collected
from the tail vein at 0, 20, 40, 60, 90 and 120 min in the GTT and 0,
20, 40 and 60 min in the ITT. Blood glucose concentrations were
determined by using a glucometer (Contour XT, Bayer, Germany). For
the GTT, plasma insulin concentrations were determined at 0, 20, and
40 min by using an enzyme-linked immunosorbent ELISA assay (Cat.
No. 80-INSMSU-E10, ALPCO) according to the manufacturer’s
instructions.
2.8. Insulin-stimulated and contraction-stimulated glucose uptake
in isolated muscles
Fed mice were anesthetized by an intraperitoneal injection of pento-
barbital (10 mg/100 g body weight) and xylocain (0.5 mg/100 g body
weight) before the soleus and extensor digitorum longus (EDL) muscles
were excised and suspended at resting tension in incubation chambers
(model 610/820M, DMT, Denmark) containing KrebseRinger buffer
(KRB; 117 mM NaCl, 4.7 mM KCl, 2.5 mM CaCl2, 1.2 mM KH2PO4,
1.2 mM MgSO4, 0.5 mM NaHCO3, pH 7.4) supplemented with 0.1%
bovine serum albumin (BSA), 2 mM Na-pyruvate, and 8 mM Mannitol.
During the entire incubation period, the buffer was maintained at 30 C
and continuously gassed with carbogen (95% O2 and 5% CO2). After
w30 min preincubation, basal, submaximal (100 mU/ml) and maximal
(10,000 mU/ml) insulin-stimulated muscle glucose uptake was deter-
mined during the last 10 min of a 30 min stimulation period by adding
1 mM [3H]-2-DG (0.028 MBq/ml) and 7 mM [14C]-Mannitol (0.0083
MBq/ml) to the incubation medium. For contraction-stimulated glucose
uptake, the muscles were electrically stimulated to contract (1 s train/MOLECULAR METABOLISM 40 (2020) 101028  2020 The Authors. Published by Elsevier GmbH. This is
www.molecularmetabolism.com15 s, 0.2 ms pulses, 100 Hz, 30 V; MultiStim System-D330, Harvard
Apparatus) for 10 min. 2-DG uptake during contraction was measured
by adding 1 mM [3H]-2-DG (0.028 MBq/ml) and 7 mM [14C]-Mannitol
(0.0083 MBq/ml) to the incubation medium immediately before initi-
ation of muscle contraction. After incubation, the muscles were har-
vested, washed in ice-cold saline, blotted dry, and quickly frozen in
liquid nitrogen. Uptake of 2-DG was determined as described in the
literature [27].
2.9. Contraction-stimulated FA oxidation in isolated soleus muscles
Contraction-stimulated exogenous palmitate oxidation in isolated so-
leus muscle was measured in a manner similar to that in the literature
[17]. In summary, excised soleus muscles from anesthetized mice
were mounted at resting tension (w5 mN) in vertical incubation
chambers (Radnoti, Monrovia, CA) containing 30 C carbogenated
(95% O2 and 5% CO2) KRB supplemented with 5 mM glucose, 2% fat-
free BSA, and 0.5 mM palmitate. Afterw20 min of preincubation, the
incubation buffer was replaced with KRB additionally containing [1e
14C]-palmitate (0.0044 MBq/ml). To seal the incubation chambers,
mineral oil (Cat. No. M5904, SigmaeAldrich) was added on top.
Exogenous palmitate oxidation was measured at rest and during
25 min contractions (18 trains/min, 0.6 s pulses, 30 Hz, 60 V). After
incubation, incubation buffer and muscles were collected to determine
the rate of palmitate oxidation as previously described [17,28].
Palmitate oxidation was determined as CO2 production (complete FA
oxidation) and acid-soluble metabolites (representing incomplete FA
oxidation). As no difference was observed in complete and incomplete
FA oxidation between genotypes, palmitate oxidation is presented as a
sum of these 2 forms.
2.10. Mitochondrial respiration of permeabilized skeletal muscle
fibers
After excision, tibialis anterior (TA) muscles were immediately trans-
ferred to ice-cold BIOPS buffer (10 mM Ca-EGTA, 0.1 mM free calcium,
20 mM imidazole, 20 mM taurine, 50 mM K-MES, 0.5 mM DTT,
6.56 mM MgCl2, 5.77 mM ATP, 15 mM phosphocreatine, pH 7.1).
Adipose and connective tissue were removed, and muscle fibers were
mechanically separated into small fiber bundles (w3 mg) with fine
forceps to maximize surface area and minimize diffusion limitations.
Permeabilization of fiber bundles was performed by a 30-min saponin
treatment (30 mg/mL in BIOPS) on a rotator at 4 C. After per-
meabilization, fiber bundles were washed for at least 30 min in MiR05
buffer (0.5 mM EGTA, 3 mM MgCl2, 60 mM K-lactobionate, 20 mM
taurine, 10 mM KH2PO4, 20 mM Hepes, 110 mM sucrose, 1 g/L BSA,
pH 7.1) before analyses. Mitochondrial respiration was measured in
duplicates in permeabilized muscle fiber bundles under hyperoxic
conditions ([O2]w400-200 mM) at 37 C in MiR05 medium by using
the Oxygraph-2k (Oroboros Instruments, Innsbruck, Austria). Complex I
supported leak respiration was measured after the addition of 5 mM
pyruvate, 10 mM glutamate, and 2 mM malate. Maximal complex I
supported oxidative phosphorylation (OXPHOS) capacity (CIP) was
measured after the addition of ADP (4 mM). Complex IþII supported
OXPHOS capacity (CIþIIP) was measured after the addition of succinate
(10 mM). Electron transfer system (ETS) capacity through complex IþII
was measured after sequential addition of 0.5 mM FCCP. Finally, ETS
capacity through complex II (CII) was achieved by adding 1 mM rote-
none to inhibit complex I. After each respiration protocol, permeabilized
fiber bundles were extracted from the respiration chamber and
weighed after vacuum drying, and data are expressed as oxygen flux
relative to muscle dry weight.an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 3
Original Article2.11. Muscle glycogen, nucleotide, AMPD activity and lactate
measurements
Muscle glycogen content was determined by a fluorometric method as
glycosyl units after acid hydrolysis of 10e15 mg wet weight muscle
samples [29]. Muscle specimens from quadriceps muscle were
extracted in perchloric acid and analyzed for nucleotides by reverse-
phase HPLC. AMPD activity was measured in quadriceps muscle by
adding 2 ml muscle homogenate to 1000 ml of the reagent solution
containing 12.5 mM AMP and the formation of IMP was analyzed by
HPLC. Kinetic properties for AMPD (Vmax and Km) were analyzed in
muscle homogenate in the presence of 15 mM, 0.1 mM, 0.06 mM, and
0.04 mM AMP, and the formation of IMP was quantified by HPLC as
reported in the literature [30]. Muscle lactate concentration was
determined in crushed quadriceps muscle by a fluorometric method
previously described [29].
2.12. mRNA isolation, reverse transcription and real-time PCR
A whole EDL muscle (w10 mg) and w25 mg of quadriceps muscle
were crushed in liquid nitrogen and subsequently homogenized before
RNA was isolated by the guanidine thiocyanate phenol-chloroform
method [31]. The pellet was washed twice in 75% EtOH (20 C)
and centrifuged for 5 min at 12,000 g and 4 C between washes. The
pellet was vacuum dried after last wash and resuspended in 1 ml/(mg
initial muscle) 0.1 mM EDTA. RNA concentration was determined by
using a Nanodrop1000 spectrophotometer (Thermo Fischer Scientific,
Waltham, USA) and RNA purity was determined by the 260/280 nm
ratio. Reverse transcriptase reaction was performed on 3 mg of total
RNA by using the Superscript II RNase H- system (ThermoFisher
Scientific, Waltham, USA) as previously described [32]. The mRNA
content of specific genes was determined by fluorescence-based real-
time PCR (ABI PRISM 7900 Sequence Detection System, Applied
Biosystems). The forward and reverse primers and TaqMan probes
were either designed from mouse-specific sequence data (Entrez-NIH
and Ensembl, Sanger Institute) by using computer software (Primer
Express, Applied Biosystems) or purchased as kits from ThermoFisher
Scientific. PCR amplification was performed in triplicates of 10 ml with
10 ng of cDNA as described in the literature [33] and with TATA-Box
Binding Protein (TBP) as the endogenous control. TBP has been
described as an endogenous reference gene [34], and we found that
TBP was unaffected by the intervention and genotype in this study. A
detailed list of primer and probe sequences is provided in
supplemental 1. The cycle threshold (Ct) values of the unknown
samples were converted to an amount by using a relative standard
curve derived from a dilution series of a representative pool. For each
sample, the amount of the specific mRNA analyzed was then divided
by the mRNA amount of the housekeeping gene (TBP) for assay
normalization.
2.13. Muscle processing
Muscles were homogenized in ice-cold buffer (10% glycerol, 20 mM
Na-pyrophosphate, 150 mM NaCl, 50 mM Hepes 1% NP-40, 20 mM
b-glycerophosphate, 10 mM NaF, 2 mM PMSF, 1 mM EDTA, 1 mM
EGTA, 10 mg/ml aprotinin, 10 mg/ml leupeptin, 2 mM Na3VO4, and
3 mM benzamidine, pH 7.5) by using a TissueLyser II (QIAGEN, Hilden,
Germany). Subsequently, homogenates were rotated end-over-end at
4 C for 1 h. Muscle lysate was obtained as supernatant from ho-
mogenate by centrifugation for 20 min at 16,000 g and 4 C. Protein
abundance in muscle homogenates and lysates was determined in
triplicate by the bicinchoninic acid method with BSA as protein stan-
dards (Thermo Fisher Scientific, Waltham, USA).4
 2020 The Authors. Published by Elsevier G2.14. Glycogen synthase (GS)-activity
GS-activity in muscle homogenates was measured in 96-well micro-
titer assay plates (Unifilter 350 plates; Whatman, Cambridge, UK) as
described in the literature [35]. GS-activity was reported as a per-
centage of fractional velocity (% FV) and calculated as 100 x activity in
the presence of 0.17 mM glucose-6-phosphate (G6P) divided by ac-
tivity in the presence of 8 mM G6P (saturated).
2.15. SDS-PAGE and Western blotting
Muscle lysates were prepared in sample buffer and heated for 5 min at
96 C. Equal amounts of protein were loaded on self-cast gels and
separated by SDS-PAGE. Gels were transferred to polyvinylidene
fluoride membranes (Merck, Darmstadt, Germany) by using semidry
blotting. Membranes were incubated for 5 min in TBST containing
either 2% skim milk or 3% BSA and subsequently incubated overnight
at 4 C with primary antibody. A detailed list of antibodies is in the
supplemental material (Supplemental 2). Proteins with bound primary
and secondary antibodies were visualized by chemi-luminescence and
a digital imaging system (ChemiDoc MP System, BioRad, California,
USA). Linearity was assessed for all proteins to ensure that the ob-
tained band intensity was within the dynamic range.
2.16. Statistical analyses
Data are presented as means  SEM unless stated otherwise. Dif-
ferences between AMPKa control and imdKO mice were analyzed by
Students t-test or 2-way ANOVA with or without repeated measure-
ments as appropriate and specified in the figure legends. The Stu-
denteNewmaneKeuls test was used for post hoc testing. Statistical
analyses were performed in Sigmaplot (version 13.0; SYSTAT, Erkrath,
German), and P  0.05 was used as the significance level.
3. RESULTS
3.1. Time course of skeletal muscle-specific deletion of AMPKa1
and a2
To define the earliest time point at which full deletion of the catalytic
AMPKa1 and a2 protein had occurred in myofibers, we investigated
the AMPK subunit levels 1, 3, and 8 weeks after tamoxifen-induced
gene deletion. One week after the last tamoxifen injection, the
mRNA content of AMPKa1 and AMPKa2 in EDL muscle was reduced to
w58% and w0%, respectively, compared to tamoxifen-treated
AMPKa double-floxed control mice (Figure 1A, B). These changes in
AMPKa gene expression were also present at 8 weeks and resulted in
a marked reduction in AMPKa1 and near complete deletion of AMPKa2
protein content (Figure 1CeD and Supplementary Fig S3F). Thus, the
AMPKa1 protein level was reduced to w60% in AMPKa imdKO
compared to control EDL muscle 1 week after tamoxifen treatment and
decreased further to w30% at 3 weeks after tamoxifen treatment
ended (Figure 1C). The protein content of AMPKa2 in EDL muscle from
AMPKa imdKO was reduced tow30 andw8% at 1 and 3 weeks after
tamoxifen treatment, respectively (Figure 1D).
A similar pattern for tamoxifen-induced reduction in AMPKa1 and
AMPKa2 protein levels was also observed in quadriceps muscle
(Supplementary Fig S3AeB). Notably, protein levels of AMPKa1 and
AMPKa2 in skeletal muscle from AMPKa imdKO mice measured 3
weeks after tamoxifen treatment ended corresponded to levels
observed in the previously described conventional (chronic) AMPKa
muscle-specific double knockout (mdKO) mouse model [16] (right bar
in Figure 1CeD). The remaining amount of AMPKa1 protein in whole
muscle samples from AMPKa imdKO mice is also found in theMOLECULAR METABOLISM 40 (2020) 101028
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Figure 1: Tamoxifen-induced deletion of AMPKa subunits in adult mice. AeF: Muscle-specific deletion of AMPKa1 and a2 was obtained by expressing a tamoxifen-inducible
Cre-recombinase construct driven by the human skeletal muscle actin promotor. The tamoxifen treatment protocol comprised 3 single injections (40 mg/kg bw) separated by 48 h,
and mice were investigated 1, 3, and 8 weeks after the last tamoxifen injection. For the vehicle experiment, all mice received injections of sunflower oil. Gene expression of
AMPKa1 and a2 subunits was measured in EDL muscle. Protein levels of AMPKa1 and a2 were measured in EDL and heart from control and AMPKa imdKO mice. These data
from the AMPKa imdKO model were compared to the conventional AMPKa double KO model (AMPKa mdKO) with chronic lack of AMPK function. Protein levels were measured by
immunoblotting, and gene expression was measured by real time PCR and presented relative to TATA-Box Binding Protein (TBP). Data have are normalized to control mice
(¼100%). Data are given as means  SEM (n ¼ 5e6 within each group). One-way ANOVA was used for comparing 1, 3, and 8 weeks to vehicle control within AMPKa imdKO
mice. An additional t-test was applied to compare AMPKa imdKO with control mice within each time point. *p  0.05, **p  0.01, and, ***p  0.001 for difference from
corresponding control mice. ##p  0.01 and ###p  0.001 for difference from corresponding AMPKa imdKO vehicle. yyyp  0.001 for difference from 1 week AMPKa imdKO.conventional AMPKa mdKO model and probably is derived from the
non-muscle cells (e.g., blood cells, adipocytes, endothelial cells) in the
crude muscle sample preparations. We expected the expression inMOLECULAR METABOLISM 40 (2020) 101028  2020 The Authors. Published by Elsevier GmbH. This is
www.molecularmetabolism.comnon-muscle cells would be unaffected because of the skeletal muscle
specificity of the HSA promotor [16]. AMPKa1 and AMPKa2 protein
levels in the heart muscle remained similar between genotypes afteran open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 5
Table 2 e Tissue weight in control and AMPKa imdKO mice.
Tissue Weight (mg) p-value
control imdKO
Tibialis anterior 42  1 43  1 0.49
Heart 101  3 98  3 0.52
WAT 200  14 245  37 0.28
Liver 991  79 988  78 0.98
Kidney 134  6 136  10 0.90
Weight (mg) of tibialis anterior muscle, heart, white subcutaneous adipose tissue
(WAT), liver, and kidney was investigated 3 weeks after tamoxifen treatment. Data are
given as means  SEM (n ¼ 8e12).
Original Articletamoxifen treatment (Figure 1EeF and Supplementary Fig S3G),
verifying that KO of the catalytic AMPK subunits indeed is specific for
skeletal muscle myofibers. The AMPKb2-associated heterotrimer
complexes account for w95% of the total AMPK pool in mouse EDL
muscle (a2b2g1w70%, a2b2g3w20% and a1b2g1w5%) [36],
and in accordance, the marked reduction in AMPKa muscle protein
levels observed in the present model is accompanied by a corre-
sponding reduction in protein levels of the regulatory AMPK subunits
b2 and g1, and AMPK g3 tended to be reduced (Supplementary
Figs S3CeF). In absolute values, these protein levels resemble those
in skeletal muscle of the conventional AMPKa mdKO mouse model.
Collectively, these data suggest that a maximal reduction in AMPKa1
and AMPKa2 protein levels is observed at the earliest 3 weeks after
tamoxifen treatment ended. Based on these observations, our chosen
time point for all subsequent experiments was 3 weeks.
3.2. Body composition and resting metabolism remain unaffected
by inducible KO of AMPKa1 and a2 in skeletal muscle
Body composition of control and AMPKa imdKO mice was investigated
before and 3 weeks after ended tamoxifen treatment by using mag-
netic resonance scanning (Table 1). Before tamoxifen treatment, no
differences were observed between genotypes, both had normal
growth rates and were born with the expected mendelian ratio (data
not shown). A decrease in body weight (w3%) and an increase in fat
mass (w10%) were observed in both genotypes 3 weeks after
tamoxifen relative to before tamoxifen treatment. A minor decrease in
lean body mass (w3%) was observed in AMPKa imdKO but not in
control mice after tamoxifen treatment. No significant difference be-
tween genotypes in lean body mass was evident before and after
tamoxifen treatment. Careful dissection and weighing of individual
organs revealed a similar weight and appearance of muscle, heart,
subcutaneous adipose tissue, liver, and kidney from AMPKa imdKO
and control littermates (Table 2). Resting metabolism during the light
and dark periods on the chow diet was comparable between control
and AMPKa imdKO mice (Supplementary Figs S4AeB). We also
investigated the ability to switch substrate utilization toward FA
oxidation, by subjecting the mice to 2 days of an HFD and a 24-hour
fasting regimen. The HFD intervention lowered RER from w0.95 to
w0.80 in both genotypes during the light period, and RER increased
similarly in the 2 genotypes during the dark period (RER fromw0.80 to
w0.85; Supplementary Figs S4A and C). Compared to the chow diet,
the 24-hour fasting intervention lowered RER markedly in the light
period, and RER declined further during the dark period (RERw0.73 to
w0.71 in both genotypes) with no difference between genotypes
(Supplementary Figs S4DeE). Together, these data suggest that
resting metabolism under these experimental conditions is similarly
covered by FA oxidation in AMPKa imdKO and control mice. OxygenTable 1 e Body composition of control and AMPKa imdKO mice.
Pretamoxifen
treatment
3 weeks post
tamoxifen treatment
Main
effect
Interaction
control imdKO control imdKO
Weight (g) 26.3  0.4 26.3  0.5 25.7  0.5 25.3  0.4 *** e
Fat mass (g) 2.0  0.2 1.8  0.2 2.2  0.1 2.1  0.1 * e
LBM (g) 21.9  0.3 22.3  0.4 21.8  0.4 21.5  0.3 e p ¼ 0.003
Body composition was investigated before (pre) and 3 weeks after (post) tamoxifen
treatment. Data are given as means  SEM (n ¼ 20). *p < 0.05 and ***p < 0.001
for significant difference from pretreatment independently of genotype.
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diet interventions showed no difference between AMPKa imdKO and
control littermates (Supplementary Figs S4FeP).
Collectively, these observations demonstrate that body composition,
resting metabolism, and metabolic flexibility, that is, the ability to
adjust metabolism according to different feeding and fasting regimes,
remain unaffected by inducible deletion of AMPKa subunits in skeletal
muscle of adult mice.
3.3. Normal whole-body insulin action and insulin-stimulated
glucose uptake in isolated skeletal muscle from AMPKa imdKO mice
Whole-body insulin action and muscle insulin sensitivity were
investigated to determine whether inducible deletion of muscle
AMPKa in adult mice was associated with the development of in-
sulin resistance. Following an intraperitoneal GTT, blood glucose
concentration increased similarly and showed a comparable dy-
namic response in the two genotypes (Figure 2A). Plasma insulin
concentrations, determined before, 20 and 40 min after the glucose
challenge, were also similar in the two genotypes (Figure 2B). An
intraperitoneal insulin tolerance test (ITT) revealed comparable
whole-body insulin action in the 2 genotypes (Figure 2C). Collec-
tively, these data demonstrate that both whole-body insulin and
glucose tolerance remain intact in mice with acute deletion of AMPK
activity in skeletal muscle myofibers. Because skeletal muscle is
responsible for the majority of glucose uptake during in vivo insulin
stimulation [37], 2-DG uptake in isolated skeletal muscle was
examined in the presence of a submaximal (100 mU/ml) and
maximal (10,000 mU/ml) insulin concentration. Both submaximal
and maximal insulin-stimulated glucose uptake in soleus and EDL
muscles were comparable between AMPKa imdKO mice and control
littermates (Figure 2DeE). In addition, insulin-stimulated signaling
in EDL muscle at the level of Akt (Akt Thr308) and its downstream
target TBC1D4 (TBC1D4 Thr642) were comparable between geno-
types, suggesting that insulin signaling to GLUT4 translocation was
regulated similarly in muscles from the 2 genotypes (Figure 2FeH).
Overall, these findings demonstrate that acute deletion of AMPK
catalytic activity in skeletal muscle does not affect whole-body in-
sulin action or the ability of insulin to stimulate glucose uptake in
isolated skeletal muscle.
3.4. Inducible deletion of AMPKa in adult mice impairs running
performance and lowers muscle glycogen content
In accordance with observations in mouse models with embryonic
and hence chronic deletion of AMPK function in skeletal muscle
[9,10,16,18], a reduction in maximal treadmill running speed was
also found in AMPKa imdKO mice relative to control littermates
(Figure 3A). Notably, aw15% reduction in maximal treadmill runningMOLECULAR METABOLISM 40 (2020) 101028
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Figure 2: Normal insulin action despite acute deletion of catalytic AMPK function in skeletal muscle. AeB: 3 weeks after the last tamoxifen injection, control and AMPKa
imdKO mice were fasted for 5 h before they were given an intraperitoneal injection of glucose (2 g/kg body weight) dissolved in a 0.9% saline solution. Blood was sampled from the
tail vein and analyzed for glucose concentration by a glucometer before (0 min) and 20, 40, 60, 90, and 120 min after injection. Plasma insulin levels were determined at 0, 20, and
40 min by using an insulin ELISA assay (n ¼ 10e12). C: For the insulin tolerance test (ITT), mice were fasted for 2 h, and insulin was injected intraperitoneally (1 U/kg body weight,
Actrapid, Novo Nordisk, Bagsværd, Denmark). Tail vein blood glucose concentration was measured before (0 min), 20, 40, and 60 min after injection (n ¼ 10e12). DeE: Isolated
EDL and soleus muscles from control and AMPKa imdKO mice were incubated for 30 min in the absence (basal) or presence of 100 mU/ml and 10,000 mU/ml insulin, and muscle
glucose uptake was determined by measuring the accumulation of intracellular [3H]-2-deoxyglucose (2DG) (n ¼ 6e8). FeH: Key insulin signaling intermediates in EDL muscle
from control and AMPKa imdKO mice were investigated by immunoblotting and are given as representative immunoblots. Data are given as means  SEM. Two-way RM ANOVA
was used to investigate the effect of genotype and time (GTT and ITT) or genotype and insulin concentrations (2DG uptake). ###p  0.001 for significantly different from basal
(0 min). **p  0.01 and ***p  0.001 for significantly different compared to basal. xxp  0.01 and xxxp  0.001 for significantly different from 100 mU/ml. Line indicates main
effect.
MOLECULAR METABOLISM 40 (2020) 101028  2020 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
www.molecularmetabolism.com
7
Figure 3: Acute deletion of muscle AMPK impairs maximal running speed and reduces muscle glycogen content and UGP2 mRNA. A: Maximal running speed during an
incremental running test on a treadmill was assessed in control and AMPKa imdKO mice 1 and 3 weeks after last tamoxifen injection and compared to before tamoxifen treatment
(pre; n ¼ 10e20 within each group). B: Muscle glycogen content in quadriceps muscle (normalized to control mice) was measured 1, 3, and 8 weeks after tamoxifen-induced
deletion of AMPKa and compared to vehicle control groups (n ¼ 5e6 within each group). C: 3 weeks after last tamoxifen injection, muscle glycogen in quadriceps muscle from
control and AMPKa imdKO mice was measured in the rested state and after 30 min of treadmill exercise at the same relative intensity (n ¼ 8e13). D: Glycogen synthase activity
was measured as fractional activity in the presence of 0.2 mM G6P and given relative to saturated conditions (8 mM G6P) (n ¼ 8e13). E: Protein levels of GLUT4, HKII, GP, GS, and
UGP2 in quadriceps muscle were measured by immunoblotting in control and AMPKa imdKO mice 3 weeks after last tamoxifen injection (n ¼ 5e6). UGP2 mRNA content in
quadriceps muscle was determined 1, 3, and 8 weeks after the last tamoxifen injection and compared to the vehicle group (sunflower oil; n ¼ 5e6). One-way ANOVA was used for
comparing 1, 3, and 8 weeks to vehicle control within AMPKa imdKO mice. An additional t-test was applied to compare AMPKa imdKO with control mice within each time point.
The effect of exercise was investigated by a two-way ANOVA (C and D). Data are given as means  SEM. *p  0.05, **p  0.01, and, ***p  0.001 for effect of genotype within
a time point. ###p  0.001 for difference from vehicle in AMPKa imdKO mice. xxp  0.01 for main effect of exercise. Line indicates main effect.
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speed was observed as early as 1 week after tamoxifen-induced
AMPKa gene deletion. This early response to AMPKa gene deletion
was also found for skeletal muscle glycogen content. Thus, glycogen
concentration in quadriceps muscle was decreased by w25% in
AMPKa imdKO at 1, 3, and 8 weeks after tamoxifen treatment ended
(Figure 3B).
To evaluate whether the metabolic stress induced by treadmill exercise
differed between genotypes, we measured muscle glycogen concen-
tration before and after 30 min of treadmill exercise (Figure 3C).
Although resting muscle glycogen content was lower in AMPKa imdKO
relative to control mice, the ability to utilize muscle glycogen (glycogen
degradation) during treadmill exercise was similar between the two
genotypes (Figure 3C). Moreover, the activity of the glucose-
incorporating enzyme - GS - was elevated in muscle from AMPKa
imdKO mice compared to control mice (Figure 3D). The content of key
proteins involved in glucose uptake (GLUT4 and HKII) and glycogen
degradation (glycogen phosphorylase (GP)) were similar in muscle
from AMPKa imdKO and control mice. Notably, UDP-glucose pyro-
phosphorylase 2 (UGP2), but not GS protein content, was lower in
quadriceps muscle from AMPKa imdKO mice than in control mice
(Figure 3E). UGP2 is essential for glycogen synthesis because it gen-
erates UDP-glucose [38] to be incorporated into glycogen chains
mainly catalyzed by GS. Analyses of the time course experiment
revealed that UGP2 gene expression was reduced by w40% in
quadriceps muscle from AMPKa imdKO mice 1 week after ended
tamoxifen-induced AMPKa gene deletion (Figure 3F). This observation
indicates that AMPK is involved in the regulation of UGP-2 gene
expression, and we hypothesize that the concurrent lowering of muscle
glycogen content in muscle from AMPKa imdKO mice is related to this
change in UGP-2 expression.
These observations suggest that AMPK is required for treadmill running
performance and for maintaining resting muscle glycogen content
potentially through regulation of UGP2. By contrast, the ability of
skeletal muscle to use glycogen as an energy source during exercise
remains unaffected. Because maximal running performance differed
between genotypes, the following treadmill running was performed at
a relative exercise intensity (% of maximal running capacity) of each
mouse.Figure 4: Regulation of myocellular nucleotide pool during exercise. Overview of c
during exercise leads to ATP regeneration through the adenylate kinase reaction (2 ADP/
AMP in the cell, AMP is deaminated to IMP through the enzyme AMP deaminase (AMPD
poxanthine (HX), which can leave the muscle cell, potentially causing a nucleotide loss. c
phosphorylase, Pi: Inorganic phosphate, NH3: Ammonia.
MOLECULAR METABOLISM 40 (2020) 101028  2020 The Authors. Published by Elsevier GmbH. This is
www.molecularmetabolism.com3.5. AMPK is required for maintaining muscle nucleotide balance
during exercise
Exercise increases the turnover of ATP in skeletal muscle, and ATP
regeneration through the adenylate kinase reaction is therefore
important for maintaining cellular ATP levels. To avoid the accumu-
lation of intracellular AMP, the muscle cell deaminates AMP to IMP
catalyzed by the enzyme AMPD (Figure 4). Treadmill exercise for
30 min at the same relative intensity decreased muscle ATP levels in
both genotypes, but to a greater extent in AMPKa imdKO mice than in
control littermates (36% vs. 14% reduction in AMPKa imdKO and
control mice, respectively; Figure 5A). Although muscle ADP content
remained unaffected and similar in the two genotypes (Figure 5B), a
significant increase in muscle AMP content was observed in response
to treadmill exercise (Figure 5C). Notably, 30 min of treadmill exercise
at the same relative intensity was associated with a 7-fold increase in
IMP in muscle from AMPKa imdKO mice, with no detectable increase
in muscle in control littermates (Figure 5D). Lower ATP levels during
exercise accompanied by accumulation of IMP suggest a disturbance
in muscle energy balance when AMPKa imdKO mice perform treadmill
exercise (Figure 4). Intracellular IMP, formed during exercise, can be
degraded to inosine (INO) and hypoxanthine (HX), which can pass
through the muscle cell membrane and hence may represent a po-
tential loss of nucleotide precursors from the exercising muscle [39].
Adenosine (ADO) increased similarly in both genotypes in response to
exercise (p¼ 0.16 for the main effect of exercise; Figure 5E). However,
both HX (p ¼ 0.07 for the effect of genotype) and INO (p ¼ 0.08 for
interaction between genotype and intervention) tended to be elevated
in exercised muscle from AMPKa imdKO only (Figure 5FeG). Collec-
tively, these findings suggest that AMPK is required for maintaining the
skeletal muscle nucleotide balance during exercise.
The enzyme adenosine monophosphate deaminase 1 (AMPD1) is
highly expressed in skeletal muscle, catalyzes the deamination of AMP
to IMP, and therefore plays a key role in the purine nucleotide cycle.
Notably, muscle AMPD enzyme activity (measured under saturated
AMP concentrations) tended to increase in response to exercise in
AMPKa imdKO and remained unchanged in muscle of control litter-
mates (p ¼ 0.08 for interaction between intervention and genotype;
Figure 5H). However, neither a genotype-dependent difference inellular processes regulating cellular nucleotide balance. The increasing ATP utilization
AMP þ ATP), which increases accumulation of AMP. To avoid a large accumulation of
). Intracellular IMP, formed during exercise, can be degraded to inosine (INO) and hy-
N-II: Cytosolic nucleotidase II, cN-IA: Cytosolic nucleotidase IA, PNP: Purine nucleoside
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Figure 5: AMPK is necessary to maintain the cellular nucleotide pool during exercise. AeG: Control and AMPKa imdKO mice performed 30 min of treadmill exercise at the
same relative intensity and were compared to corresponding resting mice. Concentration of adenosine triphosphate (ATP), adenosine diphosphate (ADP), adenosine monophosphate
(AMP), inosine monophosphate (IMP), hypoxanthine (HX), adenosine (ADO), and inosine (INO) were measured in quadriceps muscle (n ¼ 6e8). HeI: AMPD activity and AMPD1
protein content were measured in quadriceps muscle (n ¼ 6e8). Data are given as means  SEM. Two-way ANOVA was used for statistical analyses of genotype and exercise.
**p  0.01 and ***p  0.001 for significant effect of genotype. xxp  0.01 and xxxp  0.001 for difference from resting. Line indicates main effect.
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Table 3 e AMPD kinetic properties.
WT imdKO p-value
Vmax (mmol $ min
1 $ g1) 479  47 541  83 0.35
Km (mM) 0.27  0,05 0.37  0,13 0.46
Kinetic properties for AMPD (Vmax and Km) in basal quadriceps muscle were analyzed
in homogenate in the presence of 15 mM, 0.1 mM, 0.06 mM, and 0.04 mM AMP, and
the formation of IMP was quantified by HPLC. Data are given as means  SEM
(n ¼ 6e8).kinetic properties in resting muscles (Table 3 and Suppl. Fig. S3K) nor
AMPD1 protein content explains this observation (Figure 5I).
Collectively these data demonstrate that AMPK is necessary for
maintaining the cellular nucleotide pool during exercise. Next, we
investigated whether reduced ATP regeneration in muscle from
AMPKa imdKO mice was related to impaired substrate uptake and/or
utilization during exercise and muscle contraction.
3.6. Similar substrate utilization during exercise and muscle
contraction in control and AMPKa imdKO mice
Substrate utilization in control and AMPKa imdKO mice during tread-
mill exercise was investigated at the same relative intensity (60% of
individual maximal running speed). RER before exercise was compa-
rable in the 2 genotypes (w0.72) and increased similarly during
30 min of treadmill exercise (averaged 0.78  0.01 and 0.79  0.01
for control and AMPKa imdKO mice, respectively; Figure 6A). Upon
cessation of exercise, RER declined to pre-exercise levels with no
difference between genotypes. These findings suggest that exercise at
the same relative intensity exerts a similar metabolic response in
control and AMPKa imdKO mice. In accordance, the measurement of
exogenous palmitate oxidation in isolated soleus muscles revealed that
FA oxidation was similar between genotypes at rest and increased to
the same extent in response to electrically stimulated muscle con-
tractions (Figure 6B). Impaired FA oxidation in mice with chronic
deletion of AMPK activity in skeletal muscle (AMPKa mdKO) has been
associated with reduced expression of FA handling transport proteins
(CD36 and FABPpm) [16,40]. However, the protein content of these FA
transporters was similar in control and AMPKa imdKO mice (Figure 6C
and Suppl. Fig. S3H).
The literature on AMPK-deficient mouse models has reported impaired
mitochondrial function and/or expression of mitochondrial proteins
[9,15,41]. To investigate the effect of AMPKa deletion in adult mice on
mitochondrial function, we measured mitochondrial respiration rates in
permeabilized fibers from TA muscle. Mitochondrial respiration was
similar in the two genotypes when analyzed in the successive pres-
ence of malate þ glutamate þ pyruvate (Leak), ADP (CIP), succinate
(CIþIIP), FCCP (ETS CIþII), and rotenone (ETS CII) (Figure 6D). These
observations are in line with similar protein levels of subunits in
complex IeV of the mitochondrial electron transport chain (Figure 6E
and Suppl. Fig. S3I).
Collectively, these findings suggest that the phenotypic trait in the
AMPK-deficient mouse models in the literature is a consequence of
chronic deletion that probably does not reflect the consequences of
lacking AMPK activity acutely in skeletal muscle.
3.7. Normal muscle glucose uptake during in vivo exercise and
ex vivo muscle contractions in AMPKa imdKO mice
Treadmill exercise for 30 min increased AMPK phosphorylation at
Thr172, a surrogate marker for AMPK activation, in quadriceps muscle
from control mice; this effect was absent in AMPKa imdKO miceMOLECULAR METABOLISM 40 (2020) 101028  2020 The Authors. Published by Elsevier GmbH. This is
www.molecularmetabolism.com(Figure 7A and Suppl. Fig. S3J). Similarly, treadmill exercise increased
phosphorylation of TBC1D1 Ser231 in quadriceps muscle from control
but not in muscle from AMPKa imdKO mice (Figure 7B). This obser-
vation was not due to a difference in TBC1D1 protein levels because
these were similar in quadriceps muscle from control and AMPKa
imdKO mice. In the present study, we observed generally lowered
phosphorylation of ACC Ser212 in muscle from AMPKa imdKO mice,
and the ability to increase ACC Ser212 phosphorylation in response to
exercise was maintained (Figure 7C and Suppl. Fig. S3J). This finding
may either suggest that other kinases than AMPK are capable of
phosphorylating ACC Ser212 during exercise or that AMPK-induced
phosphorylation of ACC Ser212 occurs in the non-muscle cells in
the crude muscle sample preparations. Studies investigating
contraction-stimulated and exercise-stimulated glucose uptake in
skeletal muscle by using other AMPK-deficient mouse models have
suggested no or a partial role of AMPK [9,12,14e16,42]. In conven-
tional AMPKa mdKO mice, exercise is associated with markedly
elevated blood glucose levels (increase from w7 mM to w12.0 mM
during exercise) [16]. However, in this study, we found that 30 min of
treadmill exercise resulted in a minor increase in blood glucose levels
in both control and AMPKa imdKO mice that occurred concomitantly
with a similar increase in muscle lactate content (Figure 7DeE).
Glucose uptake in TA, soleus, EDL, and quadriceps muscle during
exercise was similar between control and AMPKa imdKO mice
(Figure 7F). These data demonstrate that muscle glucose uptake
during in vivo exercise is not compromised by muscle-specific deletion
of AMPK catalytic activity in adult mice. To further illuminate this
matter, contraction-stimulated 2-DG uptake was assessed in isolated
EDL and soleus muscles from control and AMPKa imdKO mice. During
tetanic muscle contractions, glucose uptake increased to a similar
extent in isolated soleus and EDL muscles from control and AMPKa
imdKO mice (Figure 7GeH). Muscle force development during this
electrical stimulation protocol showed no difference between geno-
types in EDL muscle (Suppl. Fig. S5A) but was significantly lower
(w23% lower at all time points) in soleus muscle (p ¼ 0.05) from
AMPKa imdKO mice than from control littermates (Suppl. Fig. S5B).
Thus, although force development was generally lower for soleus
muscle from AMPKa imdKO mice, the decline in force development
over time (fatigue) showed a similar pattern in both genotypes. Force
development during electrically stimulated single twitch stimulation
resulted in comparable force development (Suppl. Fig S5C). Ex vivo
contractions increased phosphorylation of AMPKa Thr172 in control
EDL and soleus muscles, and phosphorylation of AMPKa Thr172 in
AMPKa imdKO muscle at rest was reduced and increased modestly in
soleus muscle in response to contractions (Suppl. Figs 5DeE and S5J).
Both basal and contraction-stimulated phosphorylation of AMPK
downstream targets, ACC Ser212 and TBC1D1 Ser231, were reduced
in EDL muscle from AMPKa imdKO mice (Suppl. Figs 5FeG and S5J).
However, in response to contractions, phosphorylation of ACC Ser212
and TBC1D1 Ser231 in soleus muscle increased similarly in both
genotypes (Suppl. Figs S5HeJ). ACC and TBC1D1 protein levels in
soleus were comparable in control and AMPKa imdKO mice (data not
shown), and TBC1D1 protein content was lower (w25%) in EDL
muscle from AMPKa imdKO mice than from control mice (data not
shown).
Collectively, these data demonstrate that AMPK is dispensable for
contraction-stimulated glucose uptake in skeletal muscle and that the
signaling axis leading to increased glucose uptake, at least in glycolytic
quadriceps and EDL muscles, can be mediated independently of
TBC1D1 phosphoregulation.an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 11
2Figure 6: AMPK is dispensable for regulation of muscle substrate utilization and mitochondrial function. A: RER before, during, and after 30 min of a single treadmill
exercise at approximately 60% of individual maximal running speed (n ¼ 18e20). B: Palmitate oxidation was measured ex vivo in resting or contracting soleus muscles from
control and AMPKa imdKO mice (n ¼ 15e18). C. Protein levels of plasma membrane fatty acid binding protein (FABPpm) and cluster of differentiation (CD) 36 were analyzed in TA
muscle by immunoblotting (n ¼ 8e13). D: Mitochondrial respiration rates were measured during cumulative addition of substrates in permeabilized TA fibers (n ¼ 9e12).
Abbreviations: CIP: Maximal complex I respiration, CIþIIP: Maximal complex IþII linked respiration (capacity for oxidative phosphorylation), ETS (CIþII): Electron transport system
capacity (uncoupled respiration) through complex I and II, ETS (CII): Electron transport system capacity through complex II. E: Protein levels of mitochondrial subunits for complex I,
II, III, IV, and V in TA muscle were determined by immunoblotting (n ¼ 17e18). Data are given as means  SEM. The effect of exercise and genotype was investigated by two-way
ANOVA. xxxp  0.001 for difference from resting. Line indicates main effect.
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Figure 7: AMPK is not required for exercise and contraction-stimulated glucose uptake in skeletal muscle. AeC: Control and AMPKa imdKO mice were either rested or
performed 30 min treadmill exercise at the same relative intensity. Phosphorylation of AMPKa Thr172, TBC1D1 Ser231, and ACC Ser212 was determined in quadriceps muscle by
immunoblotting (n ¼ 8e13). DeE: Blood glucose concentration and muscle lactate concentration in quadriceps muscle measured under resting conditions and after 30 min of
treadmill exercise (n ¼ 8e13). F: Muscle glucose uptake during 30 min of treadmill exercise was measured in TA, soleus, EDL, and quadriceps muscle from control and AMPKa
imdKO mice (n ¼ 8e13). GeH: Isolated EDL and soleus muscle from control and AMPKa imdKO mice were electrically forced to contract, and glucose uptake was measured in
resting and contracting muscles (n ¼ 4e8). Data are given as means  SEM. The effect of genotype and exercise/muscle contraction was investigated by two-way ANOVA.
**p  0.01 and ***p  0.001 for significant effect of genotype. xp  0.05, xxp  0.01 and xxxp  0.001 for difference from resting. Line indicates main effects.
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The central role of AMPK as a gatekeeper in the regulation of skeletal
muscle metabolism is mainly based on AMPK-deficient mouse models
with chronic lack of AMPK function. However, results derived from
such models are potentially biased by confounding adaptations due to
the lifelong AMPK deficiency (including embryonic development), as
emphasized by marked defects in metabolic proteins, mitochondrial
function, and extreme exercise intolerance in some of these conven-
tional models. In an attempt to minimize the influence of these con-
founding factors and study the direct and acute effects of AMPK
deficiency, we generated a new transgenic mouse model with
tamoxifen-inducible muscle-specific deletion of catalytic AMPK activity
in adult mice (AMPKa imdKO).
The literature has reported that whole-body deletion of AMPKa2 leads
to greater degradation of ATP in skeletal muscle during exercise and is
associated with accumulation of AMP and IMP [43]. However, in that
study, the whole body AMPKa2 KO mice performed exercise at the
same absolute intensity as the control littermates. Today, we know that
these findings were biased because the maximal running capacity of
this KO model is reduced compared to WT control mice. Therefore,
these observations may be related to a difference in exercise workload
between genotypes rather than a direct consequence of a lack in AMPK
activity. Notably, Lee-Young and co-workers reported accelerated ATP
degradation but similar AMP concentrations during exercise in muscle
from AMPKa2 KD mice compared to control mice, although exercise
was performed at the same relative exercise intensity [10]. The study
also reported a marked impairment in mitochondrial respiratory ca-
pacity (w32 and 50% impairment in complex I and IV activities,
respectively); therefore, we speculate that the accelerated ATP
depletion in muscle from AMPKa2 KD mice was the result of a reduced
capacity for aerobic ATP repletion due to mitochondrial dysfunction. In
the present study, ATP degradation was also accelerated in muscle
from AMPKa imdKO mice, despite intact mitochondrial function and
that these mice were running at the same relative exercise intensity.
This suggests that AMPK activation during exercise is necessary for
maintaining myocellular ATP levels during exercise. The greater ATP
degradation during exercise in combination with lower muscle
glycogen content in AMPKa imdKO mice may also explain the lower
maximal running speed observed in these mice. Compared with the
literature, these observations were independent of muscle glucose
uptake, substrate utilization, and mitochondrial function.
The role of AMPK in the regulation of substrate utilization during ex-
ercise has been investigated in different mouse models with chronic
deletion of AMPK activity [9,16,17,44]. AMPKb1b2MKO mice show
increased reliance on FA oxidation during exercise (decreased RER) [9],
but direct interpretation of this observation is compromised by extreme
exercise intolerance (w57% reduction in maximal running speed) and
hence a dramatically lower absolute running speed during treadmill
exercise. By contrast, deletion of both AMPKa isoforms (AMPKa
mdKO) or the upstream kinase LKB1 (LKB1 KO) in skeletal muscle
results in increased reliance on glucose utilization during exercise
(increased RER) [16,17]. This may be a consequence of impaired FA
oxidation due to lowered expression of fat transport proteins (e.g.,
CD36, FABPpm) and lowered mitochondrial capacity/enzyme activity
reported for these mice [15e17]. In this study, we observed normal
substrate utilization during in vivo exercise and ex vivo contractions of
isolated muscles, and intact expression of FA transporter proteins and
mitochondrial respiratory function. Collectively, these observations
support the notion that alterations in substrate utilization in mouse
models with chronic deletion of AMPK activity are due to persistent14
 2020 The Authors. Published by Elsevier Galterations in the protein expression profile, mitochondrial function, or
extreme exercise intolerance rather than the consequences of lacking
acute AMPK-related regulation.
One of the proposed roles of AMPD is to prevent a large increase in
ADP by removing AMP, hereby favoring ATP formation by the adenylate
kinase reaction [45]. Thus, we interpret the trend toward increased
AMPD activity and massive formation of IMP in skeletal muscle from
AMPKa imdKO mice during exercise as a protective mechanism to
avoid accumulation of AMP. In vitro studies have reported that AMPD
activity is enhanced during muscle contractions in correspondence
with elevated Hþ as a result of lactate formation [46,47]. However,
muscle lactate concentration increased similarly in response to exer-
cise in control and AMPKa imdKO mice, suggesting that factors rather
than muscle Hþ accumulation contribute to the elevated AMPD activity
in muscle from AMPKa imdKO mice. For in vitro AMPD activity mea-
surements, the muscle homogenate was diluted w500 fold for the
assay procedure, probably eliminating the possible influence of the
soluble factors in the muscle. This suggests the presence of a regu-
lation in vivo during exercise in AMPKa imdKO mice that is preserved
during in vitro AMPD activity measurements. Phosphatase treatment
has been demonstrated to alter the affinity of AMPD for its substrate
AMP while the Vmax remains unchanged [30]. This finding suggests
that allosteric regulations other than protein phosphorylation have
increased maximal AMPD activity in muscle from exercising AMPKa
imdKO mice in the present study.
Although AMPK activation by pharmacological means demonstrates that
AMPK is sufficient to increase muscle glucose uptake [6e8], the pro-
posed necessary role of AMPK in the regulation of contraction-stimulated
muscle glucose uptake has been studied intensively in various transgenic
mouse models with conflicting findings. Some studies have reported
intact glucose uptake during ex vivo muscle contractions
[13,15,19,20,22]; other studies have reported a partially decreased ability
to increase muscle glucose uptake in response to contractile activity
under some experimental conditions [9,11e15]. Moreover, glucose
uptake during exercise is impaired in AMPKb1b2MKO mice but re-
mains intact in AMPKamdKO and LKB1-KOmice [9,16,17]. In this study,
we used an inducible AMPKa KO mouse model and observed that AMPK
is dispensable for regulating glucose uptake in response to in vivo ex-
ercise and ex vivo muscle contractions.
TBC1D1 has been suggested to be involved in AMPK-mediated signaling
that regulates GLUT4 translocation to increase muscle glucose uptake
during muscle contractions [48]. Other studies have reported reduced
phosphorylation of TBC1D1 at Ser231 inmuscle of AMPK-deficient mice
in response to muscle contractions [9,16,49e51]. Moreover, muscle
from TBC1D1-deficient mouse models shows reduced contraction-
stimulated and exercise-stimulated glucose uptake [52e54], sug-
gesting that the AMPK-TBC1D1 signaling axis is required for regulating
glucose uptake during exercise. However, the TBC1D1 KOmousemodel
is associated with impaired GLUT4 expression in skeletal muscle,
complicating the overall interpretation of those findings. Overexpression
of TBC1D1 mutated to alanine at 4 phosphorylation sites in skeletal
muscle (Ser231Ala, Thr499Ala, Thr590Ala, and Ser621Ala) seems not
to affect GLUT4 protein content and remains associated with a marked
reduction (22%) in contraction-stimulated glucose transport [55]. By
contrast, mutation of a single phosphorylation site on TBC1D1
(Ser231Ala) does not compromise contraction-stimulated and exercise-
stimulated glucose uptake [56]. In the present study, contraction-
stimulated TBC1D1 phosphorylation at Ser231 did not increase in
glycolytic muscles (quadriceps and EDL) from AMPKa imdKO mice,
albeit muscle glucose uptake increased similarly in both genotypes.
Recently, our research group clarified these seemingly discrepantMOLECULAR METABOLISM 40 (2020) 101028
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findings of AMPK-TBC1D1 signaling in regard to contraction-stimulated
muscle glucose uptake. Thus, we convincingly show that AMPK and
TBC1D1 are necessary and important for maintaining elevated glucose
uptake in skeletal muscle in the immediate period after, but not during,
exercise and contraction [57]. Altogether, these findings support the
concept that glucose uptake can be regulated independently of TBC1D1
phosphorylation at Ser231, and we speculate that muscle contractile
activity leads to an activation of a broad range of intracellular signaling
events that promote glucose uptake and fat oxidation during exercise,
independently of AMPK.
All experiments in the present study were performed at room tem-
perature and hence below mouse thermoneutrality. Recent evidence
suggests that mild cold stress induced by ambient housing may
confound the experimental outcome in mice [58]. However, McKie and
colleagues observed that exercise-induced gene expression and AMPK
activation in muscle were comparable between experiments per-
formed at room temperature and thermoneutrality [59]. This indicates
that at least the acute exercise responses in skeletal muscle in this
study would also have been observed at thermoneutrality.
Notably, the promptly reduced muscle glycogen content (1 week after
tamoxifen treatment ended) in AMPKa imdKO mice was accompanied
by a corresponding reduction in UGP2 gene expression. Support for a
direct link between AMPK activation and UGP2 mRNA has been pro-
vided by the transcriptomic profiling (microarray analysis) of muscles
from AMPKg3R225Q transgenic mice, AMPKg3/ knockout mice, and
AICAR-treated wild-type mice [60]. Thus, increased AMPK activity,
either by introducing an activating AMPKg3 mutation (AMPKg3R225Q)
or AMPK activation by AICAR, induced an increase in UGP2 mRNA, and
genetic deletion of AMPKg3 (AMPKg3/) induced a corresponding
reduction. Furthermore, the AMPKg3 gain of function mutation in pig
muscle (AMPKg3R200Q) leads to a 3-fold increase in UGP2 protein
levels [61]. Based on mutational cell experiments, GS is considered
rate-limiting for glycogen synthesis, and UGP2 is generally considered
to play a minor role in glycogen storage [62]. However, we speculate
that UGP2 may contribute to glycogen storage capacity by promoting
glucose flux toward GS and may explain the lower muscle glycogen
content observed in AMPKa imdKO mice.
In conclusion, we have generated a new mouse model with inducible
skeletal muscle-specific deletion of the catalytic AMPKa subunits in
adult mice that allows the study of the direct effect(s) of AMPK in
muscle metabolism. Acute deletion of AMPK activity in adult mouse
muscle reveals that intracellular mediators other than AMPK are suf-
ficient to regulate glucose uptake and substrate utilization in response
to exercise and muscle contractions. However, AMPK is central for
maintaining cellular nucleotide balance during exercise, because
increased deamination of AMP to IMP is observed in muscle from
AMPKa imdKO mice during exercise. Moreover, acute deletion of
muscle AMPKa in adult mice promptly reduces muscle glycogen
content and lowers UGP2 expression. These observations may explain
the lower maximal treadmill running speed in AMPKa imdKO observed
1 week after AMPKa gene deletion.
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